Dextrose injection contain source of water and calories, and is capable of inducing diuresis depending on the clinical condition of the patient. Dextrose injections are sterile, non-pyrogenic, and does not contain bacteriostatic or antimicrobial agents. It is intended for intravenous administration. This intravenous solution is indicated for use in adults and pediatric patients as sources of calories and water for hydration. Dosage of dextrose injection is dependent upon the age, weight, and clinical condition of the patient as well as laboratory determinations.
Market Dynamics
Increasing launches and approval of novel products, increasing adoption of inorganic growth strategies such as collaboration and acquisition by key players operating in the market and rising demand for dextrose for first-aid treatment as instant nutrition therapy in critical care are expected to drive the growth of global dextrose injection market over the forecast period. For instance, in July 2015, B. Braun Medical Inc. received the U.S. Food and Drug Administration approval for 70% Dextrose for Injection in a 2L flexible container.
Key features of the study
• This report provides in-depth analysis of the global dextrose injection market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global dextrose injection market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Pfizer Inc., Amphastar Pharmaceuticals Inc., Shangai Haixin group Co. Ltd., Seqirus GmbH, Baxter International Inc., Shandong Qidu Pharmaceutical, Sanctus drugs and pharmaceuticals Pvt., Hospira Inc., B Braun Medical Ltd., Aurobindo Pharmaceuticals Ltd., and SteriMAx Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global dextrose injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dextrose injection market
Market Segmentation
• By Product Type
o 5% Dextrose Injection
o 10% Dextrose Injection
o 50% Dextrose Injection
o 70% Dextrose Injection
o Others
• By Application
o First-aid Treatment
o Sports
o Trophotherapy
o Others
• By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• Global Dextrose Injection Market, By Region
o North America
 U.S.
 Canada
o Latin America
 Brazil
 Mexico
 Argentina
 Rest of Latin America
o Europe
 Germany
 U.K.
 France
 Italy
 Spain
 Russia
 Rest of Europe
o Asia Pacific
 China
 India
 Japan
 Australia
 South Korea
 ASEAN
 Rest of Asia Pacific
o Middle East
 GCC
 Israel
 Rest of Middle East
o Africa
 South Africa
 Central Africa
 North Africa
• Key Players
o Pfizer Inc
o Amphastar Pharmaceuticals Inc
o Shangai Haixin group Co Ltd
o Seqirus GmbH, Baxter International Inc
o Shandong Qidu Pharmaceutical
o Sanctus drugs and pharmaceuticals Pvt
o Hospira Inc., B Braun Medical Ltd
o Aurobindo Pharmaceuticals Ltd
o SteriMAx Inc

Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
 Market Definition and Scope
o Executive Summary
 Market Snapshot, By Product Type
 Market Snapshot, By Application
 Market Snapshot, By Distribution Channel
 Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
 Drivers
 Restraints
 Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Approval
o Collaboration/Merge/Acquisition
o Regulatory Landscape
o PEST Analysis
o Porter’s Five Forces Analysis
o Epidemiology
o Robust Pipeline Analysis
4. Global Dextrose Injection Market, By Product Type, 2021 – 2033, (USD Bn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022– 2033
 Segment Trends
o 5% Dextrose Injection
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o 10% Dextrose Injection
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o 50% Dextrose Injection
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o 70% Dextrose Injection
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Others
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
5. Global Dextrose Injection Market, By Application, 2021 – 2033, (USD Bn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022 – 2033
 Segment Trends
o First-aid Treatment
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Sports
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Trophotherapy
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Others
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
6. Global Dextrose Injection Market, By Distribution Channel, 2021 – 2033, (USD Bn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022 – 2033
 Segment Trends
o Hospital Pharmacies
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Retail Pharmacies
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Online Pharmacies
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
7. Global Dextrose Injection Market, By Region, 2021 – 2033, (USD Bn)
o Introduction
 Market Share Analysis, By Region, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, For Regions, 2022–2033
 Regional Trends
o North America
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o U.S.
o Canada
o Latin America
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
 Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profile
 Pfizer Inc
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 Amphastar Pharmaceuticals Inc
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 Shangai Haixin group Co. Ltd
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 Seqirus GmbH
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 Baxter International Inc
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 Shandong Qidu Pharmaceutical
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 Sanctus drugs and pharmaceuticals Pvt
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 Hospira Inc
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 B Braun Medical Ltd
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 Aurobindo Pharmaceuticals Ltd
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
 SteriMAx Inc
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About Us